Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T12:50:27.331Z.
Calculation as of: 2026-10-06T12:50:27.331Z.
Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f9f7ef7d03019e78f4201474ef0c74f9c2a497de6c29d743f28e52983e243880
EARNINGS YIELD
N/A
EARNINGS YIELD AVG TTM
N/A
EARNINGS YIELD AVG 3Y
N/A
EARNINGS YIELD AVG 5Y
N/A
EARNINGS YIELD AVG 10Y
N/A
EARNINGS YIELD AVG 15Y
N/A
EARNINGS YIELD AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Amylyx Pharmaceuticals, Inc.
Market Cap
$3.09B
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.15B
Earnings Yield
0.83%
TTM Avg
0.82%
3Y Avg
0.82%
5Y Avg
0.82%
Market Cap
$3.16B
Earnings Yield
N/A
TTM Avg
0.44%
3Y Avg
0.44%
5Y Avg
0.44%
Market Cap
$2.87B
Earnings Yield
4.65%
TTM Avg
3.82%
3Y Avg
2.33%
5Y Avg
2.33%
Market Cap
$3.44B
Earnings Yield
11.04%
TTM Avg
8.17%
3Y Avg
6.43%
5Y Avg
6.43%
Market Cap
$2.69B
Earnings Yield
10.21%
TTM Avg
9.07%
3Y Avg
6.61%
5Y Avg
6.61%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Amylyx Pharmaceuticals, Inc. (AMLX) | $3.09B | N/A | N/A | N/A | N/A |
| Arcutis Biotherapeutics, Inc. (ARQT)vs › | $3.15B | 0.83% | 0.82% | 0.82% | 0.82% |
| Denali Therapeutics Inc. (DNLI)vs › | $3.16B | N/A | 0.44% | 0.44% | 0.44% |
| Enliven Therapeutics, Inc. (ELVN)vs › | $3.25B | N/A | N/A | N/A | N/A |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.88B | N/A | N/A | N/A | N/A |
| TransMedics Group, Inc. (TMDX)vs › | $2.87B | 4.65% | 3.82% | 2.33% | 2.33% |
| AtriCure, Inc. (ATRC)vs › | $2.87B | 0.38% | 0.43% | 0.43% | 1.84% |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.44B | 11.04% | 8.17% | 6.43% | 6.43% |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.69B | 10.21% | 9.07% | 6.61% | 6.61% |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.69B | N/A | 8.33% | 6.72% | 5.70% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS YIELD |
|---|---|
| 2024-05-09 | 37.07% |
| 2024-05-08 | 36.30% |
| 2024-05-07 | 35.56% |
| 2024-05-06 | 35.21% |
| 2024-05-03 | 34.51% |
| 2024-05-02 | 35.03% |
| 2024-05-01 | 36.30% |
| 2024-04-30 | 38.71% |
| 2024-04-29 | 36.87% |
| 2024-04-26 | 39.81% |
| 2024-04-25 | 39.36% |
| 2024-04-24 | 37.27% |
| 2024-04-23 | 35.93% |
| 2024-04-22 | 35.38% |
| 2024-04-19 | 37.47% |
| 2024-04-18 | 35.38% |
| 2024-04-17 | 35.03% |
| 2024-04-16 | 34.86% |
| 2024-04-15 | 33.85% |
| 2024-04-12 | 33.36% |
| 2024-04-11 | 30.59% |
| 2024-04-10 | 28.48% |
| 2024-04-09 | 26.24% |
| 2024-04-08 | 26.04% |
| 2024-04-05 | 26.74% |
| 2024-04-04 | 26.84% |
| 2024-04-03 | 26.64% |
| 2024-04-02 | 26.74% |
| 2024-04-01 | 25.85% |
| 2024-03-28 | 24.67% |
| 2024-03-27 | 24.33% |
| 2024-03-26 | 25.57% |
| 2024-03-25 | 25.85% |
| 2024-03-22 | 25.57% |
| 2024-03-21 | 24.41% |
| 2024-03-20 | 23.59% |
| 2024-03-19 | 23.91% |
| 2024-03-18 | 24.50% |
| 2024-03-15 | 21.62% |
| 2024-03-14 | 22.10% |
| 2024-03-13 | 20.37% |
| 2024-03-12 | 20.37% |
| 2024-03-11 | 18.44% |
| 2024-03-08 | 20.85% |
| 2024-03-07 | 3.69% |
| 2024-03-06 | 3.68% |
| 2024-03-05 | 3.72% |
| 2024-03-04 | 3.66% |
| 2024-03-01 | 3.74% |
| 2024-02-29 | 3.72% |
| 2024-02-28 | 3.58% |
| 2024-02-27 | 3.69% |
| 2024-02-26 | 3.99% |
| 2024-02-23 | 3.97% |
